Skip to main content

Table 1 Clinical and biological characteristics of the patients at the initiation of hemodialysis

From: Factors associated with residual urine volume preservation in patients undergoing hemodialysis for end-stage kidney disease in Kinshasa

Variables

All group

n = 250

Initial urine volume (ml/day)

p

≤ 500

n = 123

> 500

n = 127

Age, years

52.5 ± 12.4

52.1 ± 13.3

52.8 ± 11.5

0.683

Sex, female, n (%)

78 (31.2)

44 (35.8)

34 (26.8)

0.125

Diabetes mellitus, n (%)

98 (39.2)

48 (39.0)

50 (39.4)

0.955

SBP, mm Hg

153.8 ± 27.2

153.4 ± 27.3

154.1 ± 27.3

0.821

DBP, mm Hg

84.7 ± 18.3

84.0 ± 17.5

85.2 ± 19.1

0.604

PP, mm Hg

69.1 ± 20.8

69.4 ± 19.9

68.9 ± 21.8

0.861

Hypertension, n (%)

217 (86.8)

104 (84.6)

113 (89.0)

0.302

Diuretics, n (%)

133 (53.2)

57 (46.3)

76 (59.8)

0.032

ACE inhibitors, n (%)

138 (55.2)

55 (44.7)

83 (65.4)

0.001

ARB, n (%)

29 (11.6)

12 (9.8)

17 (13.4)

0.370

Hypovolemia, n (%)

40 (16.0)

12 (9.8)

28 (22.1)

0.008

Hypervolemia, n (%)

95 (38.0)

68 (55.3)

27 (21.3)

< 0.001

eGFR-MDRD, ml/min/1.73 m2

5.0 (3.0–8.0)

(n = 240)

4.0 (3.0–8.0)

(n = 115)

6.0 (4.0–8.0)

(n = 125)

0.023

Serum creatinine, mg/dl

12.0 (8.2–17.8)

(n = 240)

13.0 (8.4–20.0)

(n = 115)

11.0 (8.0–16.0)

(n = 125)

0.036

Serum urea, mg/dl

197 (147–288)

(n = 239)

223 (168–331)

(n = 115)

187 (139–261)

(n = 124)

0.004

Serum potassium, mmol/l

5.2 ± 1.4

(n = 239)

5.4 ± 1.4

(n = 115)

4.9 ± 1.3

(n = 124)

0.007

Hemoglobin level, g/dl

8.5 ± 2.2

(n = 249)

8.2 ± 2.2

(n = 122)

8.8 ± 2.2

(n = 127)

0.042

Proteinuria, g/24 h

(n = 77)

(n = 26)

(n = 51)

0.343

 <  1, n (%)

22 (28.6)

6 (23.1)

16 (31.4)

 

 1–3, n (%)

41 (53.2)

13 (50.0)

28 (54.9)

 

 >  3, n (%)

14 (18.2)

7 (26.9)

7 (13.7)

 

Serum albumin, g/l

36.8 ± 7.3

(n = 234)

35.6 ± 7.4

(n = 116)

38.1 ± 7.0

(n = 118)

0.007

Interstitial initial nephropathy, n (%)

23 (9.2)

9 (7.3)

14 (11.0)

0.311

Left ventricular hypertrophy, n (%)

101 (42.8)

(n = 236)

55 (47.8)

(n = 115)

46 (38.0)

(n = 121)

0.200

Congestive heart failure, n (%)

86 (34.4)

47 (38.2)

39 (30.7)

0.212

≥ 3 times hemodialysis weekly, n (%)

116 (46.4)

60 (48.8)

56 (44.1)

0.458

  1. Data are expressed as the mean ± standard deviation, median (interquartile range) or absolute frequency (relative frequency in percent)
  2. Abbreviations: SBP systolic blood pressure, DBP diastolic blood pressure, ACE angiotensin conversion enzyme, ARB angiotensin receptor blockers, eGFR estimated glomerular filtration ratio, MDRD modification of diet in renal disease